学习工作经历

• 2013年至2017年：青岛农业大学，药学，本科（导师：刘宝涛教授）
• 2017年至2020年：东北农业大学，药学，硕士（导师：李艳华教授）
• 2020年至2023年：中国科学院大学，化学生物学，博士（导师：袁曙光教授）
• 2023年12月至今：美国佛罗里达大学，药学院药物化学系，博士后（合作导师：谢文俊教授）

重要学术兼职

• 专业委员会：中国化学会会员，美国 Sigma Xi 科学研究荣誉学会会员
• 期刊审稿人：Nature Communications, American Chemical Society (ACS), Royal Society of Chemistry (RSC), Frontiers Journals
• 特刊客座编辑：Frontiers in Pharmacology（Reviewer Editor of Experimental Pharmacology and Drug Discovery Section）

重要学术奖项

• 2023-2024年，ESI 高被引文章
• 2024-2025年，ESI 高被引文章
• 2025-2026年，ESI 高被引文章

代表性论文

• Yuzheng Wu¹, Xiaoxue Ren¹, Dezhi Xiao¹, Pei Liu, You Ke, Wenqiang Cui*, Paul K Chu*, Huaiyu Wang*, Sacrificing Knight for Pawn‐Queen Promotion: Sonosensitive Nano‐Xanthiums Orchestrate NO to Retain H2O2 for Antibiofilm Therapy, Advanced Materials, 2025: e21809.
• Natalia Gelfand¹, Vojtech Orel¹, Wenqiang Cui¹, Jiří Damborský, Chenglong Li, Zbyněk Prokop*, Wen Jun Xie*, and Arieh Warshel*, Biochemical and Computational Characterization of Haloalkane Dehalogenase Variants Designed by Generative AI: Accelerating the SN2 Step, Journal of the American Chemical Society, 2025, 147, 2747-2755.
• Haijian Li¹, Xiaolin Sun¹, Wenqiang Cui¹, Marc Xu¹, Junlin Dong¹, Babatunde Edukpe Ekundayo¹, Dongchun Ni¹, Zhili Rao¹, Liwei Guo¹, Henning Stahlberg*, Shuguang Yuan*, and Horst Vogel*, Computational drug development for membrane protein targets, Nature Biotechnology, 2024, 42, 229-242.
• Wenqiang Cui, Shuguang Yuan*, Will the hype of automated drug discovery finally be realized?, Expert Opinion on Drug Discovery, 2023, 19(3), 1-4.
• Wenqiang Cui, Junlin Dong, Shiyu Wang, Horst Vogel, Rongfeng Zou, Shuguang Yuan*, Molecular basis of ligand selectivity for melatonin receptors, RSC Advances, 2023, 13, 4422.
• Wenqiang Cui, Adnane Aouidate, Shouguo Wang, Qiuliyang Yu, Yanhua Li, Shuguang Yuan*, Discovering Anti-Cancer Drugs via Computational Methods, Frontiers in Pharmacology, 2020, 11, 733.
• Ke Liu¹, Rongfeng Zou¹, Wenqiang Cui¹, Meiqing Li¹, Xueying Wang, Junlin Dong, Hongchun Li, Hongpei Li, Peihui Wang, Ximing Shao, Wu Su, H. C. Stephen Chan*, Hongchang Li*, Shuguang Yuan*, Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV-2, ACS Pharmacology & Translational Science, 2020, 3(6), 1361-1370.